Cite Filings / PTCT / 0000102909-25-000196
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

PTC THERAPEUTICS, INC. · Filed 2025-10-30 · Acc 0000102909-25-000196

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2025-11-14 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-11-04 10-Q Quarterly Report
  • 2025-11-04 8-K Results of operations · Regulation FD disclosure
  • 2025-10-31 4 Director sold 15,666 shares at $69.50 ($1,088,787)
  • 2025-10-30 144 Sale of Securities
  • 2025-10-30 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · RTW Investments, LP 1.9%
  2. 2026-11-16 SCHEDULE 13G · Wellington Management Group LLP 6.3%
  3. 2026-05-15 SCHEDULE 13G/A · The Toronto-Dominion Bank 3.7%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…